I hold these stock.

DYOH (do your own homework.)

To-day there was a slight drop in price, but number of analysts are giving favourable reports.

What triggered my interest was better than expected results and if I am right looking at charts it shows an inverted head and shoulders. Hopefully a good sign. Also the current rate of Share price growth is about 90% pa over the last 5weeks. This is unlikely to continue indefinitely but SP could hit 850p over next few weeks.

To-day at close, there were some large buys of about 5million shares. 40million approx.

Another trigger for me was the following which should increase earnings.

Aviva to form JV in Taiwan with First FinancialAFX
LONDON (Thomson Financial) - Aviva PLC, the UK's largest insurer, said it has entered into a joint venture with First Financial Holding Co Ltd to sell insurance and pension products in Taiwan. The joint venture company, First-Aviva, will distribute long-term savings and pension products in Taiwan through an exclusive agreement with First Financial's flagship unit, First Commercial Bank. Aviva, which will have a 49 pct stake in the joint venture, added that the initial paid up capital of the new company will be 34 mln stg.First Commercial Bank is Taiwan's second largest bank network, with five mln retail customers, it added.TFN.newsdesk@thomson.comkkb/faj/slm




Date: Wednesday 25 Apr 2007
LONDON (ShareCast) - If the message gets home that Aviva will not bid for Prudential, the stock should rebound strongly, especially if Aviva can sustain its current impressive performance. There is still work to be done but, at 794.5p, the shares are a strong buy says the Independent.
Date: Tuesday 24 Apr 2007
LONDON (ShareCast) - Aviva stood out among the risers on a tough day for blue chip stocks. The life insurer posted an upbeat first quarter statement with brokers pleased with the numbers.



DYOH

A couple of gaps to fill.

Looking to fill the gap.

Aviva ends the pain in Spain to gain £500m windfall

Hundreds of thousands of long-suffering shareholders in Aviva – and, indirectly, millions of with-profits investors with Britain’s biggest insurer – stand to gain from a cash windfall of nearly £500m.

The capital inflow is equivalent to 5pc of the life company’s stock market capitalisation and is expected to be received “no later than April 30, 2013”. It results from an agreement between Aviva and Bankia – a Spanish banking conglomerate – to scrap litigation in that country about a joint venture called Aseval.

AVIVA TO SELL AVIVA USA FOR US$1.8 BILLION


Aviva plc ("Aviva") announces that it has agreed to sell Aviva USA Corporation, its US life and annuities business and related asset management operations ("Aviva USA"), to Athene Holding Ltd ("Athene"), for US$1.8 billion (£1.1 billion). Aviva will retain the North American asset management activities of Aviva Investors that are focused on third parties, and Aviva plc assets outside of the USA.

The transaction represents significant further progress in narrowing the group's focus on businesses and markets where Aviva enjoys leadership positions and is able to generate attractive returns with a high probability of success. The transaction will increase Aviva's pro forma economic capital surplus coverage ratio by 17 percentage points to 165% (or the economic capital surplus by approximately £1.1 billion) placing the group within its target range of 160-175% of required capital (FY11: 130%). The sale will reduce the group's credit risk exposure by approximately 25%, and also reduce the sensitivity of the group's economic capital results to credit spread movements by approximately 30%.

Skinny..... please hold my hand. he he, looks like the yanks are called kiljoy.
Mind dont forger skiners when its resolved.............. its a late crimbo,
Down here at the Happy Lamb pissed as a fart with sardines @ timmy

Sounds like a plan - off for some Doombar shortly.

This may be of interest in any who consider "promised" yields and projected PE.

Sold shares a little earlier and bought a smaller quantity recently, but trader Sbs over the last month.


Looking at indicators I think that the trend up will strengthen.

Ps also think undervalued, unless I am missing something.

But DYOH


Year Ending Profit (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 1,389.37 47.16p 7.9 0.0 +177.42% 25.89p 7.1%
31-Dec-13 1,465.34 49.74p 7.4 1.4 +5.47% 26.07p 7.1%
31-Dec-14 1,571.60 53.35p 6.9 1.0 +7.25% 26.12p 7.1%



Date Broker name View Closing price Old price target New price target Broker change
11-Jan-13 Citigroup Buy 380.10p - - Upgrade
09-Jan-13 Barclays Underweight 373.70p 363.00p 317.00p DownGrade
07-Jan-13 Investec Securities Buy 388.40p 517.00p 422.00p Reiteration

I am pushing this one up the hill, but I have a little support;-

If projections are right should reward, but DYOH

15 Feb UBS 450.00 Buy
15 Feb Morgan Stanley 444.00 Overweight
13 Feb Panmure Gordon 425.00 Buy
11 Feb Credit Suisse 455.00 Outperform
8 Feb JP Morgan... 443.00 Overweight
7 Feb Citigroup N/A Buy

Final Results 7th March.

Finanacial Calendar

Exane BNP Paribas Outperform 353.50 354.00 369.00 414.00 Upgrades

Worth a watch - BREAKINGVIEWS VIDEO - Insurer dividend angst overdone

VIVA ANNOUNCES SALE OF RUSSIAN LIFE AND PENSIONS OPERATIONS

Aviva plc ("Aviva") today announces the sale of Aviva Russia to Blagosostoyanie, a non-state pension fund in Russia, for a consideration of €35 million. The consideration is payable in cash and represents a modest premium to IFRS book value. This transaction is consistent with Aviva's strategy to narrow the Group's focus to businesses and markets where Aviva has leadership positions.

The transaction, which is subject to the approval of the Federal Antimonopoly Service of the Russian Federation, is expected to complete in the first half of 2013.

Mark Wilson, Chief Executive Officer of Aviva plc, said:
"We are pleased to have agreed the sale of our life and pensions operations in Russia to Blagosostoyanie. This transaction builds on the progress we have made to narrow Aviva's focus."

-ends-

Nobody seems to believes these targets.


4 Mar JP Morgan... 443.00 Overweight
1 Mar Citigroup 479.00 Buy
28 Feb Credit Suisse 455.00 Outperform
28 Feb Citigroup 479.00 Buy
22 Feb Credit Suisse 455.00 Outperform
21 Feb RBC Capital... 350.00 Sector Performer

FY part 1 of 5

Good progress on disposals and turnaround programme

£3,050m loss principally arising from the sale of the US as previously disclosed

Economic capital surplus increased by £3.5bn to £7.1bn1

2012 total dividend 19p from 26p. Final dividend 9p from 16p

Priorities: cashflow and debt reduction

Twenty seven per cent reduction in divi so a yield now of just over five % , will there be a RSA type reaction , its the sensible course of action , but no doubt market will have a knee jerk reaction.

Yep - short AV, long SL would have been a good bet yesterday!

So we need 2.70 for 7%, unlikely, but would be a decent buy then.

Oh dear!

Good job I decided to invest in ADM instead.

Although my assumption is they will give 19 as the base from which to raise.

They may well reduce next year's interim as well.